Fosinopril Versus Enalapril in the Treatment of Hypertension: A Double-Blind Study in 195 Patients-Reference-Cited by-同舟云学术

Fosinopril Versus Enalapril in the Treatment of Hypertension: A Double-Blind Study in 195 Patients

Published:1996-07 Issue:1 Volume:28 Page:1-5
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Hansson L.,Forslund T.,Höglund C.,Istad H.,Lederballe-Pedersen O.,Kristinsson A.,Segaard E.,Svensson A.,Äärynen M.,Wahrenberg H.,Wennersten G.,Kjellström T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference9 articles.

1. Inhibitor binding assay for angiotensin-converting enzyme.

2. Competitive inhibitor binding assay (CIBA) of captopril and other ACE inhibitors

3. The 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH Meeting

4. Overview of Fosinopril

5. Once-daily fosinopril in the treatment of hypertension.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Basis of Cardioprotective Effect of Antioxidant Vitamins in Myocardial Infarction;BioMed Research International;2013

2. ACE Inhibitors for the Treatment of Hypertension Drug Selection by Means of the SOJA Method;Reviews on Recent Clinical Trials;2011-01-01

3. Prevention and treatment of no-reflow;Acute Cardiac Care;2010-08-10

4. ACE-Inhibition and Physical Function: Results From the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) Study;Journal of the American Medical Directors Association;2010-01

5. Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers;American Heart Journal;2009-02